RU97116119A - DRUG FOR THE TREATMENT OF ANIMAL PYROPLASMIDOSIS AND METHOD OF ITS APPLICATION - Google Patents

DRUG FOR THE TREATMENT OF ANIMAL PYROPLASMIDOSIS AND METHOD OF ITS APPLICATION

Info

Publication number
RU97116119A
RU97116119A RU97116119/13A RU97116119A RU97116119A RU 97116119 A RU97116119 A RU 97116119A RU 97116119/13 A RU97116119/13 A RU 97116119/13A RU 97116119 A RU97116119 A RU 97116119A RU 97116119 A RU97116119 A RU 97116119A
Authority
RU
Russia
Prior art keywords
animal
ethidium bromide
drug
treatment
animals
Prior art date
Application number
RU97116119/13A
Other languages
Russian (ru)
Other versions
RU2119792C1 (en
Inventor
Е.А. Ефремова
А.С. Опанасюк
Г.И. Дейнеко
Original Assignee
Институт экспериментальной ветеринарии Сибири и Дальнего Востока СО РАСХН
Filing date
Publication date
Application filed by Институт экспериментальной ветеринарии Сибири и Дальнего Востока СО РАСХН filed Critical Институт экспериментальной ветеринарии Сибири и Дальнего Востока СО РАСХН
Priority to RU97116119A priority Critical patent/RU2119792C1/en
Priority claimed from RU97116119A external-priority patent/RU2119792C1/en
Application granted granted Critical
Publication of RU2119792C1 publication Critical patent/RU2119792C1/en
Publication of RU97116119A publication Critical patent/RU97116119A/en

Links

Claims (4)

1. Препарат для лечения пироплазмидозов животных, включающий этиотропное вещество, отличающийся тем, что в качестве последнего используют этидий бромистый (Ethidium Bromide).1. A drug for the treatment of animal pyroplasmidoses, including an etiotropic substance, characterized in that ethidium bromide (Ethidium Bromide) is used as the latter. 2. Способ лечения пироплазмидозов животных, включающий внутримышечное введение лекарственных препаратов больным животным, отличающийся тем, что животным вводят этидий бромистый двукратно, с интервалом 24 ч, в дозировке 0,5-1 мг на кг веса. 2. A method of treating animal pyroplasmidoses, including intramuscular administration of drugs to sick animals, characterized in that the animals are injected with ethidium bromide twice, with an interval of 24 hours, at a dosage of 0.5-1 mg per kg of body weight. 3. Способ по п.1, отличающийся тем, что животным вводят этидий бромистый и азидин в качестве санационной пары. 3. The method according to claim 1, characterized in that the animals are administered ethidium bromide and azidine as a debridement pair. 4. Способ по п.1, отличающийся тем, что животным первоначально вводят этидий бромистый, а затем через 24 ч азидин в дозировке 3,5 мг на кг веса. 4. The method according to claim 1, characterized in that the animals are initially injected with ethidium bromide, and then after 24 hours, azidine in a dosage of 3.5 mg per kg of weight.
RU97116119A 1997-09-24 1997-09-24 Preparation for treatment of animals with piroplasmosis and method of its using RU2119792C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97116119A RU2119792C1 (en) 1997-09-24 1997-09-24 Preparation for treatment of animals with piroplasmosis and method of its using

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97116119A RU2119792C1 (en) 1997-09-24 1997-09-24 Preparation for treatment of animals with piroplasmosis and method of its using

Publications (2)

Publication Number Publication Date
RU2119792C1 RU2119792C1 (en) 1998-10-10
RU97116119A true RU97116119A (en) 1999-01-27

Family

ID=20197543

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97116119A RU2119792C1 (en) 1997-09-24 1997-09-24 Preparation for treatment of animals with piroplasmosis and method of its using

Country Status (1)

Country Link
RU (1) RU2119792C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020977A2 (en) * 2001-08-31 2003-03-13 The University Court Of The University Of Glasgow Nucleotide repeats assay
CN118555960A (en) * 2022-04-29 2024-08-27 上海交通大学医学院附属瑞金医院 Ethidium bromide pharmaceutical composition and use thereof for treating cancer

Similar Documents

Publication Publication Date Title
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
RU95101385A (en) Products containing g-csf and tnf-binding protein
EP0346297A1 (en) A preparation for topical use in the therapeutic treatment of impotentia coeundi
DE69110289D1 (en) ADMINISTRATION OF ACTIVE SUBSTANCES TO SOUND ANIMALS.
RU97116119A (en) DRUG FOR THE TREATMENT OF ANIMAL PYROPLASMIDOSIS AND METHOD OF ITS APPLICATION
RU97120700A (en) NEW PHARMACOLOGICAL APPLICATION OF ANTAGONISTS A-II RECEPTOR
KR890007728A (en) Painkiller
RU94003799A (en) METHOD FOR TREATING ANIMAL PSOROPTOSES
RU99105324A (en) IMMUNOMODULATOR DRUG FOR THE TREATMENT OF ANIMAL MYCOPLASMOSIS AND METHOD OF ITS APPLICATION
RU2001108220A (en) DRUG FOR TREATMENT OF ANIMAL HEMOBARTONELLOSIS, PREFERREDLY CATS, AND METHOD OF ITS APPLICATION
RU95112605A (en) METHOD FOR PREVENTION AND TREATMENT OF PARASITIC AND INFECTIOUS DISEASES USING INTERLEUKIN-1
RU2002129102A (en) TREATMENT OF SEPARATE DOSES OF AGENTS WITH VASCULAR DESTRUCTIVE ACTIVITY
SU1629062A1 (en) Method for treatment of calves with colibacillosis
RU96117561A (en) METHOD OF TREATING TOXICOMANIA
RU2017485C1 (en) Method for treatment of leptospirosis at cattle
RU2002108806A (en) A method for the treatment of autoimmune arthritis in animals
RU2158129C2 (en) Method for treating the cases of lupus erythematosus
何金森 et al. COMPARATIVE ANALYSIS OF THERAPEUTIC EFFECTS OF ACUPUNCTURE IN THE TREATMENT OF HYPERTHYROIDISM
RU94000001A (en) Agent for sexual potency normalization in men
RU99112967A (en) METHOD FOR TREATMENT AND PREVENTION OF PIG DYSENTERY
RU94013606A (en) Hemostimulator
RU95120783A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU2001113054A (en) A method for the treatment of postpartum acute purulent-catarrhal endometritis of cows
RU96109937A (en) METHOD FOR TREATING PATIENTS WITH ACUTE SUBCUTANEOUS MUSCLE DAMAGE
RU96100137A (en) METHOD FOR STIMULATION OF HUMORAL AND CELLULAR IMMUNITY UNDER COLD EXPOSURE